Market Watch

The Centers for Disease Control and Prevention’s influential vaccine advisory committee plans to meet Thursday to discuss the new safety warning for Johnson & Johnson’s JNJ, +0.94% COVID-19 vaccine and whether immunocompromised people will need a booster dose of a COVID-19 shot. The CDC’s Advisory Committee on Immunization Practices has met several times during the pandemic to discuss COVID-19 vaccines. The meeting will be webcast.


Similar Posts

Leave a Reply

Your email address will not be published.